Kimball back with Ganassi and partner Novo Nordisk

Charlie Kimball

Chip Ganassi Racing Teams (CGRT) announced today that Novo Nordisk and Verizon IndyCar Series race winner Charlie Kimball will return for their fifth season with Novo Nordisk Chip Ganassi Racing (NNCGR) to begin a new multi-year deal.

NOTES OF INTEREST:

Diabetes Community Hero: Charlie Kimball has made a strong impression on the diabetes world and was dubbed by Time Magazine as a "rock star in the diabetes community." For his community service efforts, Kimball received the 2012 Jefferson Award for Public Service, which is considered the "Nobel Peace Prize of community service awards." Kimball has also been featured in the New York Times, Men's Fitness, USA Today, Sports Illustrated, and PARADE Magazine for his work in the world of diabetes. Novo Nordisk and Kimball made headlines in 2009 by sending out the first-ever pharmaceutical-branded tweet via the program's @racewithinsulin account.

Off-Track with Novo Nordisk: Novo Nordisk and the Race With Insulin program have been a fixture in the Indy car paddock since 2011 and have activated a proactive marketing effort with the message that diabetes does not have to slow you down. The No. 83 car and team are the focal point of a year-round diabetes education and awareness program that includes hospital visits, meetings with families living with diabetes and media outreach in major markets across the nation. Each year Kimball shares his story and meets with approximately 10,000 people living with diabetes.

Diabetes Pioneer: Kimball is the first licensed driver with diabetes and first licensed driver to qualify for and complete the Indianapolis 500 in the history of INDYCAR. Novo Nordisk has partnered with Kimball since he first joined INDYCAR as an Indy Lights Series driver in 2009. Diagnosed with diabetes in 2007, Kimball manages his diabetes with Novo Nordisk products both on and off the track.

Kimball 2014 at a Glance: The Verizon IndyCar Series race winner added another podium finish, four top-five finishes, and 10 top-10 finishes to his career statistics in 2014. Over the past four seasons in the series, Kimball has recorded one win, eight top-five finishes, and 28 top-10 finishes.

NNCGR QUOTEBOARD:

Camille Lee, Senior Vice President of Diabetes Marketing, Novo Nordisk: "Our partnership with Charlie and Chip Ganassi Racing has given us the opportunity to convey that diabetes doesn't have to slow you down and inspire those who are working to manage their condition. We couldn't have picked two better partners to continue that journey."

Chip Ganassi, Owner, Chip Ganassi Racing Teams, Inc.: "We are very pleased to have Novo Nordisk back with the team as they have been a tremendous partner of ours over the last four years. We also expect big things from Charlie as he continues to grow as a driver. I think 2015 will be a big year for the whole Novo Nordisk racing program."

Charlie Kimball, Driver, Novo Nordisk Chip Ganassi Racing: "I am really excited to continue to be a part of this great partnership with Novo Nordisk and Chip Ganassi Racing. The relationships we've built over the past four years, both on and off the track, are only getting stronger as I enter my fifth Verizon IndyCar Series season. From the guys at the shop prepping the car each and every week, to those within Novo Nordisk working on the Race With Insulin program, it's truly a team effort. We'll be working as hard as ever to take the No. 83 car back to victory lane in 2015 and beyond!"